Fares Noujaim, an executive vice chairman at Bank of America has left the company abruptly.» Read More
CNBC's Bob Pisani talks with William O'Brien Direct Edge CEO, about the benefits of combing the two companies.
You can't even blame the grim U.S. durable goods number on a statistical fluke. This was the most high profile data point this week, and greatly complicates the taper talk.
In the 1990s, U.S. banks used life insurance to bet that their employees would eventually die. Now those wagers are coming back to haunt Wall Street banks.
Chris Raymond, Robert W. Baird analyst, discusses details of the fifth-biggest biotech deal in history, and the expanding field of biotech cancer drugs.
T. Rowe Price Group has permanently banned about 1,300 American Airlines employees from trading among its funds in their 401(k) retirement plans.
Barbara Ryan, FTI Consulting Advisors, discusses the details of the $10.4 billion acquisition, which represents the fifth-largest biotechnology deal in history.
Central banks in Europe, the United States and Japan have no need to rush to exit the ultra-easy monetary policies they have put in place to spur growth, IMF Managing Director Christine Lagarde said.
CNBC's Jackie DeAngelis looks ahead to what are likely to be next week's top business and financial stories.
The boaters don't want the developers to get the license needed for the boatyard. And the developers don't really want to construct the boatyard. Here's why they're fighting anyway.
Electronic exchange group BATS Global Markets may merge with rival stock-exchange company Direct Edge Holdings, people familiar with the matter told The Wall Street Journal.
Toshiba, KKR and a consortium including Bain Capital are expected to participate in the final round of bids next week for Panasonic's healthcare business, sources said.
CNBC's Brian Sullivan and the Fast Money traders discuss the day's top trades and the stocks they'll be watching tomorrow.
U.S. attorney announces superseding indictment against Matthew Martoma. CNBC's Kate Kelly has the details.
Many are taking a wait-and-see approach to the re-open of the NASDAQ. But a couple have decided that a "messy open" could present some opportunities.
Global manufacturing indexes are up, yet retail results are wetting the bed...again.
Struggling retailer J.C. Penney is adopting a "poison pill" just two days after reporting its sixth straight quarter of big losses and steep revenue declines.
CNBC's Amanda Drury and the Fast Money traders discuss the day's top trades and the stocks they'll be watching tomorrow.
Wells Fargo is cutting 2,300 jobs from in the mortgage production unit,the company said on Wednesday.
The exchanges have no idea how frequently that clearly erroneous trades occur.
Lowe's profit blew past Wall Street expectations, but valuations are looking somewhat stretched. Is this the top for home improvement?
Get the best of CNBC in your inbox